While the mortality rate showed a trend towards lower fatality in the remdesivir group (7.1% compared to 11.9%), this difference was not statistically significant.
← all excerpts
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
1
—
—